Wilson Sonsini Goodrich & Rosati advised SEEIT on the deal. SEEIT announced that it has agreed to acquire a 100 percent equity interest in a commercial...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised the underwriters on the deal. ThredUp Inc. (thredUP) announced the pricing of its initial public offering of 12,000,000 shares of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised VIZIO on the deal, while Davis Polk advised the representatives of the several underwriters. VIZIO announced the pricing of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cricut, Inc. on the deal. Cricut, Inc., the creative technology company that has brought a connected platform for making to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Pinsent Masons advised 4D pharma plc on the deal. 4D pharma plc, a Leeds, UK-based pharmaceutical company leading the development...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Lifelink Systems on the deal. Oakland, California-based Lifelink Systems announced that it has completed its Series A funding round, raising...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Everlywell on the deal, while Choate represented PWNHealth. Everlywell, a leading digital health company, announced that it has acquired PWNHealth...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Savara Inc. on the deal. Savara Inc., an orphan lung disease company, announced the closing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Viz.ai on the deal. Viz.ai, the leader in AI-driven modern care coordination, announced that it has raised $71 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk advised the representatives of the underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ventyx Biosciences on the deal. Taylor Wessing advised Oppilan Pharma Limited and Zomagen Biosciences Limited. Ventyx Biosciences, a clinical-stage biotechnology...
You must be a Standard 1 Year member to access this content.
